Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Helmink BA, Ansstas G, Fields RC. Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized Therapy. Ann Surg Oncol 2021;29:1498-1501. [PMID: 34787738 DOI: 10.1245/s10434-021-11055-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Accepted: 10/25/2021] [Indexed: 11/18/2022]

For:	Helmink BA, Ansstas G, Fields RC. Biomarker-Driven Prognostication in Merkel Cell Carcinoma: A Paradigm for Personalized Therapy. Ann Surg Oncol 2021;29:1498-1501. [PMID: 34787738 DOI: 10.1245/s10434-021-11055-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Accepted: 10/25/2021] [Indexed: 11/18/2022]

Number

Cited by Other Article(s)

Minutilli E, Lachance K, Nghiem P. Cutaneous Merkel cell carcinoma (MCC): A report from the 16th Annual Meeting for Multicenter Merkel Interest Group - A supplementation to the new European guidelines 2022 on MCC. Eur J Cancer 2022;175:107-109. [PMID: 36099669 DOI: 10.1016/j.ejca.2022.07.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Accepted: 07/07/2022] [Indexed: 11/18/2022]